Cefditoren
Cefditoren
Systematic (IUPAC) name
(2,2-dimethylpropanoyloxymethyl (6R,7R)-7-([(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino)-3 -[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Identifiers
CAS number
117467-28-4
ATC code
?
PubChem
6917926
Chemical data
Formula
C 25 H 28 N 6 O 7 S 3
Mol. mass
620.721 g.mol-1
Pharmacokinetic data
Bioavailability
?
Metabolism
?
Half life
?
Excretion
?
Therapeutic considerations
Pregnancy cat.
?
Legal status
Routes
?
Cefditoren is a third-generation cephalosporin antibiotic for oral use. It is commonly marketed under the trade name Spectracef ® by Cornerstone BioPharma.
Clinical use
Main article: Cephalosporin
Indications
Cefditoren is used to treat uncomplicated skin and skin structure infections. community-acquired pneumonia , acute bacterial exacerbation of chronic bronchitis (ABECB), pharyngitis , tonsillitis , and
Formulations
Cefditoren is available as 200 mg tablets.
trade name: Spectracef
See also
Antibacterials for systemic use: beta-lactam antibiotics - cephalosporins and related (J01D )
First generation
Cefacetrile, Cefadroxil , Cefalexin , Cefaloglycin, Cefaloridine, Cefalotin, Cefapirin, Cefatrizine, Cefazedone, Cefazolin, Cefradine, Cefroxadine, Ceftezole
Second generation
Cefaclor , Cefamandole, Cefmetazole, Cefonicid, Ceforanide, Cefotiam, Cefprozil, Cefuroxime
Third generation
Cefdinir , Cefditoren , Cefetamet, Cefixime, Cefmenoxime, Cefodizime, Cefoperazone, Cefotaxime , Cefpiramide, Cefpodoxime, Cefsulodin, Ceftazidime , Ceftibuten , Ceftizoxime, Ceftriaxone , Latamoxef
Fourth generation
Cefepime , Cefpirome, Cefquinome
Other beta-lactam antibacterials
Monobactams (Aztreonam ), Carbapenems (Meropenem , Ertapenem , Imipenem , Doripenem )